Eur J Immunol. 2025 Apr;55(4):e202451516. doi: 10.1002/eji.202451516.
ABSTRACT
Autoantibodies neutralizing Type I interferons increase the risk of severe viral diseases and are linked to autoimmune conditions. The automated VIDAS assay is suitable for anti-IFN-α2 IgGs quantification, offering a swift, reliable, user-friendly, single test for clinical management.
PMID:40223598 | DOI:10.1002/eji.202451516
